High materiality7/10
TransMedics price target lowered to $90 from $100 at Evercore ISI
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Source-backed market context you can read and share without an account.
bullish
What happened, with direct paths to the underlying reporting
Evercore ISI lowered TMDX target to $90 while the current price is $70.77; target remains above market price.
Target: $90
Posted price: $70.77
Analyst firm: Evercore ISI
Analyst: Daniel Markowitz
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.